Index RUT
P/E -
EPS (ttm) -1.34
Insider Own 29.81%
Shs Outstand 139.25M
Perf Week 50.10%
Market Cap 1.10B
Forward P/E -
EPS next Y -0.11
Insider Trans 0.33%
Shs Float 98.59M
Perf Month 49.52%
Income -180.91M
PEG -
EPS next Q -0.04
Inst Own 66.02%
Short Float 12.22%
Perf Quarter 24.60%
Sales 540.28M
P/S 2.04
EPS this Y 18.56%
Inst Trans 1.45%
Short Ratio 4.87
Perf Half Y -40.58%
Book/sh 0.12
P/B 65.61
EPS next Y 73.22%
ROA -25.90%
Short Interest 12.04M
Perf Year -14.49%
Cash/sh 0.71
P/C 11.04
EPS next 5Y 12.00%
ROE -1000.48%
52W Range 4.88 - 17.34
Perf YTD -48.05%
Dividend Est. -
P/FCF -
EPS past 5Y -5.07%
ROI -30.81%
52W High -54.73%
Beta 1.37
Dividend TTM -
Quick Ratio 1.21
Sales past 5Y 40.20%
Gross Margin 56.76%
52W Low 60.86%
ATR (14) 0.51
Dividend Ex-Date -
Current Ratio 2.22
EPS Y/Y TTM 11.14%
Oper. Margin -26.21%
RSI (14) 78.74
Volatility 9.25% 6.33%
Employees 839
Debt/Eq 13.65
Sales Y/Y TTM 28.09%
Profit Margin -33.48%
Recom 1.25
Target Price 16.62
Option/Short Yes / Yes
LT Debt/Eq 13.42
EPS Q/Q 34.13%
Payout -
Rel Volume 6.69
Prev Close 5.62
Sales Surprise 2.40%
EPS Surprise -1.22%
Sales Q/Q 24.51%
Earnings Oct 30 AMC
Avg Volume 2.47M
Price 7.85
SMA20 42.65%
SMA50 36.57%
SMA200 -25.01%
Trades
Volume 16,529,817
Change 39.68%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-01-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Jul-08-24 Initiated
Barclays
Overweight
$19
Feb-09-24 Initiated
Wells Fargo
Overweight
$26
Dec-19-23 Reiterated
Needham
Buy
$16 → $18
Oct-20-23 Initiated
ROTH MKM
Buy
$22
Oct-12-22 Initiated
Jefferies
Buy
$12
Sep-12-22 Initiated
Morgan Stanley
Overweight
$13
Dec-03-21 Initiated
Goldman
Neutral
$12.50
Oct-29-21 Initiated
Loop Capital
Buy
$22
Aug-25-21 Initiated
Needham
Buy
$18
Aug-04-21 Resumed
Cowen
Outperform
$22.50
Mar-05-21 Reiterated
H.C. Wainwright
Buy
$16 → $19
Dec-21-20 Reiterated
H.C. Wainwright
Buy
$12 → $16
Oct-20-20 Initiated
Stifel
Buy
$13
Sep-03-20 Initiated
Cowen
Outperform
$12
Jun-18-20 Initiated
Northland Capital
Outperform
$9
Aug-28-19 Initiated
Canaccord Genuity
Buy
$7
Aug-05-19 Initiated
Piper Jaffray
Overweight
$7
Oct-16-17 Initiated
Lake Street
Buy
$7
Aug-14-17 Initiated
H.C. Wainwright
Buy
$4
Show Previous Ratings
Today 03:20AM
Oct-30-24 05:10PM
04:06PM
(Associated Press Finance)
04:00PM
Oct-07-24 09:00AM
09:00AM
Loading…
Sep-18-24 09:00AM
Aug-22-24 01:01AM
Aug-05-24 05:01PM
05:01PM
Jul-31-24 05:15PM
04:09PM
(Associated Press Finance)
04:00PM
Jul-29-24 09:00AM
Jul-24-24 09:00AM
Jul-10-24 09:00AM
09:00AM
Loading…
Jun-10-24 09:00AM
May-08-24 01:07PM
May-07-24 09:56PM
06:00PM
04:43PM
(Associated Press Finance)
04:00PM
May-02-24 09:00AM
Apr-26-24 07:00PM
04:41PM
Apr-17-24 09:00AM
Mar-10-24 03:24PM
Mar-08-24 11:54PM
Mar-04-24 11:52PM
Mar-01-24 12:40AM
Feb-28-24 10:14AM
04:58PM
Loading…
Feb-27-24 04:58PM
04:52PM
(Associated Press Finance)
04:01PM
Jan-29-24 09:00AM
Jan-08-24 09:00AM
08:00AM
Dec-19-23 09:00AM
Nov-07-23 10:52AM
Nov-06-23 04:43PM
04:39PM
(Associated Press Finance)
04:05PM
Nov-01-23 09:00AM
Oct-31-23 09:00AM
Oct-27-23 04:05PM
Oct-25-23 05:38PM
Oct-24-23 10:59PM
04:01PM
Oct-23-23 07:00AM
Oct-17-23 04:05PM
09:00AM
Oct-16-23 04:05PM
09:00AM
Oct-09-23 04:05PM
Oct-05-23 12:37PM
Sep-18-23 12:14PM
Sep-14-23 01:12PM
Sep-08-23 07:36PM
01:05PM
Aug-07-23 11:00AM
Aug-03-23 04:11PM
04:00PM
Jul-24-23 09:00AM
Jul-18-23 09:00AM
Jul-02-23 09:37AM
Jun-27-23 04:16PM
(Investor's Business Daily)
Jun-06-23 07:00AM
Jun-04-23 10:47AM
May-23-23 09:00AM
May-04-23 04:53PM
04:05PM
10:42AM
Apr-19-23 05:00PM
04:07PM
04:05PM
Apr-17-23 08:24AM
Apr-13-23 09:00AM
Apr-04-23 09:00AM
Mar-13-23 09:39AM
Mar-03-23 08:10PM
Feb-28-23 07:25PM
04:05PM
Feb-21-23 09:00AM
Feb-10-23 08:40AM
Feb-07-23 09:00AM
Jan-09-23 09:00AM
Jan-08-23 09:10AM
Dec-28-22 09:00AM
Dec-12-22 12:32PM
Nov-09-22 06:22AM
Nov-03-22 06:45PM
04:05PM
06:36AM
Nov-01-22 10:01AM
09:00AM
Oct-27-22 10:02AM
Oct-17-22 12:41PM
Oct-12-22 09:00AM
Oct-11-22 09:00AM
Oct-10-22 09:00AM
Oct-05-22 09:55AM
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bakst Evan Director Aug 23 '24 Buy 5.76 35,000 201,600 50,000 Aug 26 04:32 PM Pelizzon David R Director Aug 23 '24 Buy 5.89 16,978 100,000 331,696 Aug 26 04:27 PM Pelizzon David R Director Aug 22 '24 Buy 5.67 8,818 49,998 314,718 Aug 26 04:27 PM Demski David M Director Aug 21 '24 Buy 5.67 50,000 283,500 288,441 Aug 21 10:00 PM Lish Scott CHIEF OPERATING OFFICER Aug 06 '24 Option Exercise 2.80 71,500 199,925 580,861 Aug 08 05:29 PM Demski David M Director Aug 02 '24 Buy 6.56 40,000 262,400 238,441 Aug 05 02:49 PM Valentine Keith Director Aug 02 '24 Buy 6.55 39,000 255,450 82,140 Aug 05 02:48 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Jun 12 '24 Sale 10.88 50,232 546,524 245,638 Jun 14 04:30 PM Koning John Todd CHIEF FINANCIAL OFFICER Apr 24 '24 Sale 12.82 37,500 480,750 393,356 Apr 26 04:38 PM Bakst Evan Director Mar 14 '24 Buy 13.53 15,000 202,950 15,000 Mar 18 11:35 AM Blackford Quentin S. Director Mar 07 '24 Buy 12.83 20,000 256,600 572,605 Mar 08 08:55 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 06 '24 Sale 13.16 9,225 121,401 295,870 Mar 08 05:30 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 01 '24 Sale 13.30 11,825 157,272 305,095 Mar 04 08:45 PM Koning John Todd CHIEF FINANCIAL OFFICER Mar 01 '24 Sale 13.30 121,601 1,617,293 430,856 Mar 04 08:43 PM Sponsel David EVP, SALES Feb 27 '24 Sale 15.19 32,365 491,624 622,296 Feb 29 06:51 PM Lish Scott CHIEF OPERATING OFFICER Feb 27 '24 Sale 15.19 31,075 472,029 507,165 Feb 29 06:49 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 26 '24 Sale 15.05 41,560 625,478 1,188,444 Feb 28 12:21 PM Sponsel David EVP, SALES Feb 21 '24 Sale 15.34 17,820 273,359 654,661 Feb 22 06:31 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 20 '24 Sale 15.16 77,255 1,171,186 1,188,814 Feb 22 06:31 PM Lish Scott CHIEF OPERATING OFFICER Feb 21 '24 Sale 15.34 11,963 183,512 538,240 Feb 22 06:30 PM Sponsel David EVP, SALES Feb 14 '24 Sale 16.16 2,500 40,400 637,418 Feb 15 05:49 PM Sponsel David EVP, SALES Feb 02 '24 Sale 16.47 36,620 603,131 639,918 Feb 05 06:48 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 02 '24 Sale 16.51 38,556 636,560 1,266,569 Feb 05 06:46 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 05 '24 Sale 16.41 500 8,205 1,266,069 Feb 05 06:46 PM Lish Scott CHIEF OPERATING OFFICER Feb 02 '24 Sale 16.47 25,210 415,209 518,457 Feb 05 06:44 PM Sponsel David EVP, SALES Jan 16 '24 Sale 15.00 2,500 37,500 555,280 Jan 17 04:30 PM Sponsel David EVP, SALES Dec 21 '23 Sale 15.00 2,500 37,500 557,780 Dec 26 07:25 PM Demski David M Director Nov 09 '23 Buy 10.50 30,000 315,000 181,694 Nov 13 10:19 AM
Index -
P/E -
EPS (ttm) -0.97
Insider Own 52.63%
Shs Outstand 17.05M
Perf Week -14.44%
Market Cap 42.25M
Forward P/E -
EPS next Y -0.83
Insider Trans 0.44%
Shs Float 8.24M
Perf Month -15.33%
Income -17.31M
PEG -
EPS next Q -0.29
Inst Own 36.38%
Short Float 0.28%
Perf Quarter 19.12%
Sales 56.66M
P/S 0.75
EPS this Y 28.44%
Inst Trans 2.50%
Short Ratio 0.45
Perf Half Y 75.45%
Book/sh 1.01
P/B 2.40
EPS next Y 13.02%
ROA -30.51%
Short Interest 0.02M
Perf Year 42.11%
Cash/sh 1.41
P/C 1.73
EPS next 5Y -
ROE -69.97%
52W Range 1.30 - 3.71
Perf YTD 22.11%
Dividend Est. -
P/FCF -
EPS past 5Y 2.69%
ROI -43.68%
52W High -34.50%
Beta 1.33
Dividend TTM -
Quick Ratio 4.01
Sales past 5Y 10.63%
Gross Margin 59.13%
52W Low 86.88%
ATR (14) 0.17
Dividend Ex-Date -
Current Ratio 4.32
EPS Y/Y TTM 52.30%
Oper. Margin -27.90%
RSI (14) 35.00
Volatility 6.27% 5.98%
Employees 179
Debt/Eq 1.36
Sales Y/Y TTM 7.05%
Profit Margin -30.56%
Recom 1.33
Target Price 6.25
Option/Short Yes / Yes
LT Debt/Eq 1.25
EPS Q/Q 42.51%
Payout -
Rel Volume 0.40
Prev Close 2.51
Sales Surprise 14.76%
EPS Surprise 52.94%
Sales Q/Q 6.56%
Earnings Aug 05 BMO
Avg Volume 52.40K
Price 2.43
SMA20 -11.00%
SMA50 -16.02%
SMA200 12.45%
Trades
Volume 20,710
Change -3.19%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-05-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Oct-15-21 Resumed
Cowen
Outperform
$26
Apr-15-21 Initiated
Canaccord Genuity
Buy
$25
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$32
Oct-08-20 Initiated
BTIG Research
Buy
$18
Jun-02-20 Resumed
Cantor Fitzgerald
Overweight
$19 → $20
Oct-14-19 Initiated
William Blair
Outperform
Oct-14-19 Initiated
Cowen
Outperform
$17
Oct-14-19 Initiated
Cantor Fitzgerald
Overweight
$18
Oct-29-24 04:05PM
Oct-21-24 04:05PM
Sep-04-24 04:05PM
Aug-29-24 09:55AM
Aug-26-24 08:50AM
09:15AM
Loading…
Aug-09-24 09:15AM
Aug-08-24 08:50AM
Aug-05-24 12:53PM
09:10AM
08:00AM
Aug-02-24 09:00AM
Aug-01-24 09:00AM
Jul-22-24 09:00AM
Jun-13-24 08:50AM
May-15-24 05:01AM
12:53PM
Loading…
May-13-24 12:53PM
09:10AM
08:00AM
May-06-24 04:05PM
Apr-30-24 04:05PM
Apr-26-24 08:30AM
Mar-19-24 09:37AM
01:55AM
(Thomson Reuters StreetEvents)
Mar-18-24 12:52PM
09:25AM
08:00AM
Mar-08-24 09:00AM
Mar-07-24 04:05PM
Feb-06-24 08:50AM
Jan-30-24 04:05PM
12:00PM
Loading…
Jan-07-24 12:00PM
Nov-13-23 04:05PM
Nov-09-23 04:05PM
Nov-02-23 04:05PM
Oct-30-23 04:05PM
(GlobeNewswire) +6.75%
+6.08%
Sep-28-23 04:05PM
Sep-12-23 04:05PM
Aug-09-23 10:47AM
Aug-08-23 04:13AM
(Thomson Reuters StreetEvents)
Aug-07-23 09:15AM
08:00AM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-24-23 04:05PM
07:33AM
Jun-13-23 08:19AM
May-30-23 09:00AM
May-17-23 07:11AM
May-16-23 11:03AM
(Thomson Reuters StreetEvents) +19.51%
May-15-23 05:55PM
04:05PM
May-01-23 04:05PM
Apr-24-23 04:05PM
Mar-24-23 08:16AM
Mar-22-23 06:12AM
Mar-21-23 07:40AM
(Thomson Reuters StreetEvents)
Mar-20-23 05:25PM
04:05PM
Mar-06-23 04:05PM
Feb-27-23 09:00AM
Feb-14-23 06:19AM
Jan-30-23 04:05PM
Jan-23-23 09:00AM
Nov-14-22 07:55PM
04:05PM
Nov-08-22 04:05PM
Oct-31-22 04:05PM
Oct-17-22 09:00AM
Oct-04-22 08:25AM
Sep-20-22 04:05PM
Sep-19-22 10:20AM
Sep-01-22 04:05PM
Aug-05-22 12:00PM
Aug-04-22 06:55PM
04:06PM
04:05PM
Jul-25-22 04:05PM
(GlobeNewswire) +8.23%
-6.11%
Jul-21-22 04:05PM
Jul-05-22 08:25AM
Jun-21-22 08:10AM
Jun-09-22 08:25AM
May-26-22 04:05PM
May-16-22 04:05PM
May-11-22 05:55PM
04:06PM
04:05PM
May-10-22 10:45AM
May-03-22 05:15PM
May-01-22 12:00PM
Apr-25-22 04:05PM
Apr-20-22 04:05PM
Apr-12-22 07:22AM
Mar-30-22 08:25AM
Mar-22-22 10:00PM
05:25PM
04:06PM
04:05PM
Mar-16-22 04:05PM
Mar-09-22 05:35PM
04:05PM
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Adawi Kamal Officer Oct 08 '24 Proposed Sale 2.94 84,162 247,436 Oct 08 04:39 PM Adawi Kamal Officer Aug 09 '24 Proposed Sale 2.76 52,624 145,242 Aug 09 05:08 PM ABALLI JOHN President and CEO May 16 '24 Buy 1.92 40,401 77,570 40,401 May 16 08:02 PM Adawi Kamal CFO and Corporate Secretary Mar 04 '24 Sale 1.91 12,784 24,407 243,749 Mar 06 04:05 PM Adawi Kamal CFO and Corporate Secretary Feb 06 '24 Sale 1.95 6,738 13,133 181,533 Feb 08 04:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite